SynCre ATP by iForce Nutrition 200g
Creatine supplementation has been shown to be an effective
energy and power assistance program. It is also well established
that exogenous (from the outside) creatine supplementation
should be discontinued for at least a 2-week recovery period
called an “off-cycle”. This off-cycle allows the body to re-activate
its natural production of creatine and the high-powered energy
compound phosphocreatine. These are primary energy and
power compounds bio-synthesized by the body.
The synthesis of Creatine, chemically known as N-(aminoiminomethyl)-
N-methyl glycine, requires three amino acids glycine,
arginine and methionine. In its synthesis, the guanidino group of
L-arginine is transferred to glycine to form guanidinoacetate and
ornithine by a transamidinase reaction, a reaction that takes place
in the pancreas, liver and kidney. Guanidinoacetate is methylated
by S-adenosylmethione (SAMe) to form creatine. About 1 to 2
grams of creatine are biosynthesized daily and another 1 to 2
grams are obtained from diet.
SynCre ATP is a revolutionary creatine recovery system that
provides the body with the intermediary metabolites utilized in
the natural synthesis of intracellular creatine. The proprietary
SynCre ATP matrix provides precise dosages of the essential
compounds that provide for effective methyl donation supporting
the synthesis of creatine within the cell. This revolutionary
approach to off-cycle creatine resynthesis take performance
creatine supplementation to new levels. Used as an excellent
adjunct to on-cycle creatine supplements SynCre ATP allows
for extended pumps, increased power output, strength retention,
and anaerobic endurance during the off-cycle. Don’t just cycle off
creatine…cycle onto SynCre ATP.
SynCre ATP is synergistically formulated with calibrated dosages
of compounds the body utilizes in the synthesis of creatine.
Utilize this innovation to help regenerate endogenous creatine
synthesis and maintain the strength and power gains during the
required creatine off-cycle.
|
